Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 514
Filtrar
2.
J Public Health Manag Pract ; 30: S127-S129, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-39041748

RESUMEN

The Centers for Disease Control and Prevention (CDC) continues to promote the utilization of electronic health records (EHRs) to support population health management and reduce disparities. However, access to EHRs with capabilities to disaggregate data or generate digital dashboards is not always readily available in rural areas. With funding from CDC's DP-18-1815, the Division of Diabetes and Heart Disease Management (Division) at the South Carolina Department of Health and Environmental Control designed a quality improvement initiative to reduce health disparities for people with hypertension and high blood cholesterol in rural areas. With support from a nonprofit partner, the Division used qualitative evaluation methods to evaluate the extent to which practices were able to disaggregate data and report quality measures.


Asunto(s)
Registros Electrónicos de Salud , Uso Significativo , Registros Electrónicos de Salud/estadística & datos numéricos , Registros Electrónicos de Salud/tendencias , Humanos , Uso Significativo/estadística & datos numéricos , South Carolina , Estados Unidos , Centers for Disease Control and Prevention, U.S./organización & administración , Servicios de Salud Rural/tendencias , Servicios de Salud Rural/estadística & datos numéricos , Mejoramiento de la Calidad , Población Rural/estadística & datos numéricos , Población Rural/tendencias
4.
J Public Health Manag Pract ; 30(4): 467-478, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38848277

RESUMEN

CONTEXT: In 2021, the Centers for Disease Control and Prevention (CDC) launched CORE, an agency-wide strategy to embed health equity as a foundational component across all areas of the agency's work. The CDC established a definition of health equity science (HES) and principles to guide the development, implementation, dissemination, and use of the HES framework to move beyond documenting inequities to investigating root causes and promoting actionable approaches to eliminate health inequities. The HES framework may be used by state and local health departments to advance health equity efforts in their jurisdictions. OBJECTIVE: Identify implementation considerations and opportunities for providing technical assistance and support to state and local public health departments in advancing HES. DESIGN: A series of implementation consultations and multi-jurisdictional facilitated discussions were held with state and local health departments and community partners in 5 states to gather feedback on the current efforts, opportunities, and support needs to advance HES at the state and local levels. The information shared during these activities was analyzed using inductive and deductive methods, validated with partners, and summarized into themes and HES implementation considerations. RESULTS: Five themes emerged regarding current efforts, opportunities, and support needed to implement HES at state and local health departments. These themes included the following criteria: (1) enhancing the existing health equity evidence base; (2) addressing interdisciplinary public health practice and data needs; (3) recognizing the value of qualitative data; (4) evaluating health equity programs and policies; and (5) including impacted communities in the full life cycle of health equity efforts. Within these themes, we identified HES implementation considerations, which may be leveraged to inform future efforts to advance HES at the state and local levels. CONCLUSION: Health equity efforts at state and local health departments may be strengthened by leveraging the HES framework and implementation considerations.


Asunto(s)
Equidad en Salud , Gobierno Local , Equidad en Salud/tendencias , Equidad en Salud/normas , Humanos , Estados Unidos , Centers for Disease Control and Prevention, U.S./organización & administración , Gobierno Estatal , Salud Pública/métodos
6.
J Public Health Manag Pract ; 30: S6-S14, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38870354

RESUMEN

CONTEXT: Contributing to the evidence base, by disseminating findings through written products such as journal articles, is a core competency for public health practitioners. Disseminating practice-based evidence that supports improving cardiovascular health is necessary for filling literature gaps, generating health policies and laws, and translating evidence-based strategies into practice. However, a gap exists in the dissemination of practice-based evidence in public health. Public health practitioners face various dissemination barriers (eg, lack of time and resources, staff turnover) which, more recently, were compounded by the COVID-19 pandemic. PROGRAM: The Centers for Disease Control and Prevention's Division for Heart Disease and Stroke Prevention (DHDSP) partnered with the National Network of Public Health Institutes to implement a multimodal approach to build writing capacity among recipients funded by three DHDSP cooperative agreements. This project aimed to enhance public health practitioners' capacity to translate and disseminate their evaluation findings. IMPLEMENTATION: Internal evaluation technical assistance expertise and external subject matter experts helped to implement this project and to develop tailored multimodal capacity-building activities. These activities included online peer-to-peer discussion posts, virtual writing workshops, resource documents, one-to-one writing coaching sessions, an online toolkit, and a supplemental issue in a peer-reviewed journal. EVALUATION: Findings from an informal process evaluation demonstrate positive results. Most participants were engaged and satisfied with the project's activities. Across eight workshops, participants reported increased knowledge (≥94%) and enhanced confidence in writing (≥98%). The majority of participants (83%) reported that disseminating evaluation findings improved program implementation. Notably, 30 abstracts were submitted for a journal supplement and 23 articles were submitted for consideration. DISCUSSION: This multimodal approach serves as a promising model that enhances public health practitioners' capacity to disseminate evaluation findings during times of evolving health needs.


Asunto(s)
COVID-19 , Creación de Capacidad , Difusión de la Información , Salud Pública , Escritura , Humanos , Estados Unidos , Salud Pública/métodos , Escritura/normas , COVID-19/prevención & control , COVID-19/epidemiología , Difusión de la Información/métodos , Creación de Capacidad/métodos , Enfermedades Cardiovasculares/prevención & control , SARS-CoV-2 , Centers for Disease Control and Prevention, U.S./organización & administración
7.
JAMA Health Forum ; 5(5): e240862, 2024 May 03.
Artículo en Inglés | MEDLINE | ID: mdl-38787541

RESUMEN

This survey study evaluates public health priorities and trust in the Centers for Disease Control and Prevention (CDC) and state health departments among US adults after the COVID-19 pandemic.


Asunto(s)
Centers for Disease Control and Prevention, U.S. , Confianza , Estados Unidos , Humanos , Centers for Disease Control and Prevention, U.S./organización & administración , Prioridades en Salud , Gobierno Estatal , Salud Pública
8.
Am J Public Health ; 114(6): 626-632, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38603662

RESUMEN

The COVID-19 pandemic presented wide-ranging leadership challenges to public health leaders and public health organizations. In its wake, as the necessity of reconstructing public health and modernizing the Centers for Disease Control and Prevention (CDC) is considered, we reviewed reports from the Commonwealth Fund and the CDC and other leadership-focused literature to identify common themes for a new generation of public health leaders. We posit that this new generation must have the ability to communicate (build and maintain trust and accountability); forge, facilitate, and promote partnerships; connect public health and health care systems; build information systems that provide accessible, actionable data; engage in systems and strategic thinking and action; center equity and inclusivity and understand structural racism as a fundamental driver and creator of health inequities; and achieve and maintain resilience and self-care. For each of the 7 abilities, we offer a description, assess what COVID-19 taught us about the necessity of the ability for public health leaders, and offer suggestions for developing (or honing) one's skill set, mindset, and tool set in this regard. (Am J Public Health. 2024;114(6):626-632. https://doi.org/10.2105/AJPH.2024.307633).


Asunto(s)
COVID-19 , Liderazgo , Salud Pública , Humanos , COVID-19/prevención & control , COVID-19/epidemiología , Estados Unidos , SARS-CoV-2 , Centers for Disease Control and Prevention, U.S./organización & administración , Pandemias/prevención & control , Administración en Salud Pública
9.
Public Health Rep ; 139(1_suppl): 23S-29S, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38111108

RESUMEN

Vaccination disparities are part of a larger system of health inequities among racial and ethnic groups in the United States. To increase vaccine equity of racial and ethnic populations, the Centers for Disease Control and Prevention (CDC) designed the Partnering for Vaccine Equity program in January 2021, which funded and supported national, state, local, and community organizations in 50 states-which include Indian Health Service Tribal Areas; Washington, DC; and Puerto Rico-to implement culturally tailored activities to improve access to, availability of, and confidence in COVID-19 and influenza vaccines. To increase vaccine uptake at the local level, CDC partnered with national organizations such as the National Urban League and Asian & Pacific Islander American Health Forum to engage community-based organizations to take action. Lessons learned from the program include the importance of directly supporting and engaging with the community, providing tailored messages and access to vaccines to reach communities where they are, training messengers who are trusted by those in the community, and providing support to funded partners through trainings on program design and implementation that can be institutionalized and sustained beyond the COVID-19 pandemic. Building on these lessons will ensure CDC and other public health partners can continue to advance vaccine equity, increase vaccine uptake, improve health outcomes, and build trust with communities as part of a comprehensive adult immunization infrastructure.


Asunto(s)
Vacunas contra la COVID-19 , COVID-19 , Humanos , Estados Unidos , COVID-19/prevención & control , COVID-19/epidemiología , Vacunas contra la COVID-19/provisión & distribución , Vacunas contra la COVID-19/administración & dosificación , Disparidades en Atención de Salud , SARS-CoV-2 , Programas de Inmunización/organización & administración , Centers for Disease Control and Prevention, U.S./organización & administración , Adulto
11.
Am Fam Physician ; 104(3): 277-287, 2021 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-34523888

RESUMEN

Chagas disease, cysticercosis, and toxoplasmosis affect millions of people in the United States and are considered neglected parasitic diseases. Few resources are devoted to their surveillance, prevention, and treatment. Chagas disease, transmitted by kissing bugs, primarily affects people who have lived in Mexico, Central America, and South America, and it can cause heart disease and death if not treated. Chagas disease is diagnosed by detecting the parasite in blood or by serology, depending on the phase of disease. Antiparasitic treatment is indicated for most patients with acute disease. Treatment for chronic disease is recommended for people younger than 18 years and generally recommended for adults younger than 50 years. Treatment decisions should be individualized for all other patients. Cysticercosis can manifest in muscles, the eyes, and most critically in the brain (neurocysticercosis). Neurocysticercosis accounts for 2.1% of all emergency department visits for seizures in the United States. Diagnosing neurocysticercosis involves serology and neuroimaging. Treatment includes symptom control and antiparasitic therapy. Toxoplasmosis is estimated to affect 11% of people older than six years in the United States. It can be acquired by ingesting food or water that has been contaminated by cat feces; it can also be acquired by eating undercooked, contaminated meat. Toxoplasma infection is usually asymptomatic; however, people who are immunosuppressed can develop more severe neurologic symptoms. Congenital infection can result in miscarriage or adverse fetal effects. Diagnosis is made with serologic testing, polymerase chain reaction testing, or parasite detection in tissue or fluid specimens. Treatment is recommended for people who are immunosuppressed, pregnant patients with recently acquired infection, and people who are immunocompetent with visceral disease or severe symptoms.


Asunto(s)
Salud de la Familia/tendencias , Enfermedades Parasitarias/diagnóstico , Animales , Portador Sano , Gatos , Centers for Disease Control and Prevention, U.S./organización & administración , Centers for Disease Control and Prevention, U.S./tendencias , Enfermedad de Chagas/complicaciones , Enfermedad de Chagas/fisiopatología , Cisticercosis/complicaciones , Cisticercosis/fisiopatología , Humanos , Toxoplasmosis/complicaciones , Toxoplasmosis/fisiopatología , Estados Unidos
12.
Public Health Rep ; 136(5): 554-561, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34139910

RESUMEN

OBJECTIVES: Federal open-data initiatives that promote increased sharing of federally collected data are important for transparency, data quality, trust, and relationships with the public and state, tribal, local, and territorial partners. These initiatives advance understanding of health conditions and diseases by providing data to researchers, scientists, and policymakers for analysis, collaboration, and use outside the Centers for Disease Control and Prevention (CDC), particularly for emerging conditions such as COVID-19, for which data needs are constantly evolving. Since the beginning of the pandemic, CDC has collected person-level, de-identified data from jurisdictions and currently has more than 8 million records. We describe how CDC designed and produces 2 de-identified public datasets from these collected data. METHODS: We included data elements based on usefulness, public request, and privacy implications; we suppressed some field values to reduce the risk of re-identification and exposure of confidential information. We created datasets and verified them for privacy and confidentiality by using data management platform analytic tools and R scripts. RESULTS: Unrestricted data are available to the public through Data.CDC.gov, and restricted data, with additional fields, are available with a data-use agreement through a private repository on GitHub.com. PRACTICE IMPLICATIONS: Enriched understanding of the available public data, the methods used to create these data, and the algorithms used to protect the privacy of de-identified people allow for improved data use. Automating data-generation procedures improves the volume and timeliness of sharing data.


Asunto(s)
COVID-19/epidemiología , Centers for Disease Control and Prevention, U.S./organización & administración , Confidencialidad/normas , Anonimización de la Información/normas , Centers for Disease Control and Prevention, U.S./normas , Humanos , Pandemias , SARS-CoV-2 , Estados Unidos/epidemiología
13.
Workplace Health Saf ; 69(9): 435-441, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-33942679

RESUMEN

BACKGROUND: Violent workplace deaths among health care workers (HCWs) remain understudied in the extant literature despite the potential for serious long-term implications for staff and patient safety. This descriptive study summarized the number and types of HCWs who experienced violent deaths while at work, including the location in which the fatal injury occurred. METHODS: Cases were identified from the Centers for Disease Control and Prevention's National Violent Death Reporting System between 2003 and 2016. Coded variables included type of HCW injured, type of facility, and location within the facility and perpetrator type among homicides. Frequencies were calculated using Excel. FINDINGS: Among 61 HCW deaths, 32 (52%) were suicides and 21 (34%) were homicides; eight (13%) were of undetermined intent. The occupations of victims included physicians (28%), followed by nurses (21%), administration/support operations (21%), security and support services (16%), and therapists and technicians (13%). Most deaths occurred in hospitals (46%) and nonresidential treatment services (20%). Within facility, locations included offices/clinics (20%) and wards/units (18%). Among homicide perpetrators, both Type II (perpetrator was client/patient/family member) and Type IV (personal relationship to perpetrator) were equally common (33%). CONCLUSION/ APPLICATIONS TO PRACTICE: Suicide was more common than homicide among HCW fatal injuries. Workplace violence prevention programs may want to consider both types of injuries. Although fatal HCW injuries are rare, planning for all types of violent deaths could help minimize consequences for staff, patients, and visitors.


Asunto(s)
Personal de Salud/estadística & datos numéricos , Violencia Laboral/estadística & datos numéricos , Centers for Disease Control and Prevention, U.S./organización & administración , Centers for Disease Control and Prevention, U.S./estadística & datos numéricos , Humanos , Salud Laboral/estadística & datos numéricos , Sistema de Registros/estadística & datos numéricos , Estados Unidos , Lugar de Trabajo/normas , Lugar de Trabajo/estadística & datos numéricos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...